Chang KH - Search Results

1

Direct effects of HIV-1 Tat on excitability and survival of primary dorsal root ganglion neurons: possible contribution to HIV-1-associated pain.

Chi X, Amet T, Byrd D, Chang KH, Shah K, Hu N, Grantham A, Hu S, Duan J, Tao F, Nicol G, Yu Q. Chi X, et al. Among authors: chang kh. PLoS One. 2011;6(9):e24412. doi: 10.1371/journal.pone.0024412. Epub 2011 Sep 2. PLoS One. 2011. PMID: 21912693 Free PMC article.

2

Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer's disease.

Chang KH, de Pablo Y, Lee HP, Lee HG, Smith MA, Shah K. Chang KH, et al. J Neurochem. 2010 Jun;113(5):1221-9. doi: 10.1111/j.1471-4159.2010.06687.x. Epub 2010 Mar 14. J Neurochem. 2010. PMID: 20345761 Free article.

3

Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity.

Sun KH, Chang KH, Clawson S, Ghosh S, Mirzaei H, Regnier F, Shah K. Sun KH, et al. Among authors: chang kh. J Neurochem. 2011 Sep;118(5):902-14. doi: 10.1111/j.1471-4159.2011.07343.x. Epub 2011 Jul 8. J Neurochem. 2011. PMID: 21668448 Free article.

4

Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death.

Chang KH, Vincent F, Shah K. Chang KH, et al. J Cell Sci. 2012 Nov 1;125(Pt 21):5124-37. doi: 10.1242/jcs.108183. Epub 2012 Aug 16. J Cell Sci. 2012. PMID: 22899714

5

Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death.

Chang KH, Multani PS, Sun KH, Vincent F, de Pablo Y, Ghosh S, Gupta R, Lee HP, Lee HG, Smith MA, Shah K. Chang KH, et al. Mol Biol Cell. 2011 May;22(9):1452-62. doi: 10.1091/mbc.E10-07-0654. Epub 2011 Mar 9. Mol Biol Cell. 2011. PMID: 21389115 Free PMC article.

6

PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer.

Johnson EO, Chang KH, de Pablo Y, Ghosh S, Mehta R, Badve S, Shah K. Johnson EO, et al. Among authors: chang kh. J Cell Sci. 2011 Aug 15;124(Pt 16):2711-22. doi: 10.1242/jcs.084970. J Cell Sci. 2011. PMID: 21807936

7

Synthesis and in-vitro anticancer activity of 3,5-bis(indolyl)-1,2,4-thiadiazoles.

Kumar D, Kumar NM, Chang KH, Gupta R, Shah K. Kumar D, et al. Among authors: chang kh. Bioorg Med Chem Lett. 2011 Oct 1;21(19):5897-900. doi: 10.1016/j.bmcl.2011.07.089. Epub 2011 Jul 30. Bioorg Med Chem Lett. 2011. PMID: 21873049

8

Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles.

Kumar D, Maruthi Kumar N, Chang KH, Shah K. Kumar D, et al. Among authors: chang kh. Eur J Med Chem. 2010 Oct;45(10):4664-8. doi: 10.1016/j.ejmech.2010.07.023. Epub 2010 Jul 21. Eur J Med Chem. 2010. PMID: 20692741

9

Synthesis of novel indolyl-1,2,4-triazoles as potent and selective anticancer agents.

Kumar D, Narayanam MK, Chang KH, Shah K. Kumar D, et al. Among authors: chang kh. Chem Biol Drug Des. 2011 Mar;77(3):182-8. doi: 10.1111/j.1747-0285.2010.01051.x. Epub 2011 Jan 19. Chem Biol Drug Des. 2011. PMID: 21251232

10

One-pot synthesis and anticancer studies of 2-arylamino-5-aryl-1,3,4-thiadiazoles.

Kumar D, Vaddula BR, Chang KH, Shah K. Kumar D, et al. Among authors: chang kh. Bioorg Med Chem Lett. 2011 Apr 15;21(8):2320-3. doi: 10.1016/j.bmcl.2011.02.083. Epub 2011 Feb 26. Bioorg Med Chem Lett. 2011. PMID: 21429743

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,131 results

Search Page

Filters